Interestingly, a recent study using mass spectrometry found a more pronounced complement deposition in kidney biopsies of patients with ANCA-negative GN in comparison to PR3-ANCA or MPO-ANCA positive patients with GN. The gene discussed is PRTN3; the disease is ganglioneuroma.